Photoplethysmography for Diagnose Incipient Hypovolemia
Photopletysmography Detects Early Acute Blood Loss in Compensated Blood Donor Volunteers
1 other identifier
observational
60
1 country
1
Brief Summary
Hypovolemia caused by acute bleeding increased morbi-mortality in emergency and operatin rooms. Precise real-time diagnosis of incipient acute hypovolemia is lacking at the bedside. We hypothesize that the infrared-red signals of pulse oximetry are sensitive to acute changes in patient's volemia. We aimed to test this hypothesis in a cohort of healthy blood donors as a model of simulated acute hypovolemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2022
CompletedStudy Start
First participant enrolled
August 15, 2022
CompletedFirst Posted
Study publicly available on registry
August 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedMarch 1, 2023
March 1, 2022
7 months
April 12, 2022
February 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analysis of the continuous component (DC) of the photoplethysmography signal.
The DC components of photoplethysmography is measured in arbitrary units (a.u).
15 minutes
Secondary Outcomes (1)
Analysis of non-invasive arterial blood pressure (NIBP)
15 minutes
Interventions
Finger photoplethysmography in tested hand, noninvasive blood pressure and heart rate during blood donation.
Eligibility Criteria
Healthy blood donor volunteers.
You may qualify if:
- Written Inform Consent
- weight \> 50 kg,
- hemoglobin \>12.5 gr/dl
You may not qualify if:
- pregnancy,
- ≤ 12 months from delivery or abortion,
- symptoms of allergy,
- fever \>37 °C,
- infectious diseases,
- addictions,
- volunteers that received previous blood transfusions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Privado de Comunidad
Mar del Plata, Buenos Aires, 7600, Argentina
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gerardo Tusman, MD
Hospital Privado de Comunidad
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2022
First Posted
August 23, 2022
Study Start
August 15, 2022
Primary Completion
February 28, 2023
Study Completion
February 28, 2023
Last Updated
March 1, 2023
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share